It has become clear that papillary carcinomas of the thyroid often exp
ress the receptor for c-Met/hepatocyte growth factor (HGF) receptor, b
ut little is known about the role of the HGF;and c-Met system in the p
athogenesis of thyroid carcinoma, In this study, the expression of c-M
et/HGF receptor was evaluated in thyroid tissue by western blot and im
munohistochemistry, and compared with the concentration elf HGF. Clini
copathological characteristics were also compared. Fifteen of 20 papil
lary carcinomas (75%) showed c-Met bands of 145 kDa, No or only a low
frequency of c-Met expression was detected in healthy thyroid tissue (
0/5), thyroiditis or Basedow's disease (0/2), adenomatous goiters (0/8
), follicular adenomas (1/9, 11%) and undifferentiated carcinomas (0/2
), These results were confirmed by immunohistochemistry,but a relative
ly higher frequency of c-Met expression was detected in adenomatous go
iters (25%), follicular adenoma (44%) and papillary carcinoma (100%) u
sing formalin-fixed and paraffin-embedded materials,,A strong immunore
action for c-Met was observed in the tumor cytoplasm of papillary carc
inomas among the fibrous tissues situated at the periphery of the tumo
r. The densitometric:ally measured expression of c-Met had no relation
to tumor stage in papillary carcinoma, but did correlate to the conce
ntration of HGF in papillary carcinomas. In conclusion, in thyroid les
ions, c-Met was highly expressed specifically in the cytoplasm of papi
llary carcinomas. c-Met expression was not related to the aggressivene
ss of the tumor but was related to the concentration of HGF, which was
probably derived from the stroma, Also, the c-Met system might play a
role in the pathogenesis of papillary carcinoma of the thyroid.